INDICATION
STIVARGA is indicated for the treatment of patients with mCRC who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.
AUGUST 5th @7PM
Don't miss this virtual event!
Register via the following link: https:// tallen.adobeconnect.com/bay0000605/ event/registration.html
Comentários